ProfileGDS4718 / 223471_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 86% 60% 88% 83% 89% 84% 86% 87% 87% 87% 83% 86% 87% 88% 86% 85% 84% 87% 81% 85% 85% 86% 84% 88% 88% 83% 85% 88% 89% 83% 87% 84% 90% 80% 90% 86% 86% 84% 51% 87% 87% 83% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.1854290
GSM549102patient 115, normal, homogenized [OPG study]8.5475586
GSM549104patient 119, normal, homogenized [OPG study]6.1372460
GSM549108patient 138, normal, homogenized [OPG study]8.7246488
GSM549119patient 077, normal, homogenized [OPG study]8.219983
GSM549133patient 032, cancer, homogenized [OPG study]9.0769989
GSM549139patient 042, cancer, homogenized [OPG study]8.3534484
GSM549099patient 107, normal, homogenized [OPG study]8.5183286
GSM549109patient 139, normal, homogenized [OPG study]8.6701787
GSM549110patient 046, normal, homogenized [OPG study]8.8009487
GSM549114patient 063, normal, homogenized [OPG study]8.8556987
GSM549122patient 082, normal, homogenized [OPG study]8.1500683
GSM549134patient 033, cancer, homogenized [OPG study]8.6287586
GSM549136patient 036, cancer, homogenized [OPG study]8.7970487
GSM549140patient 044, cancer, homogenized [OPG study]9.0084588
GSM549111patient 047, normal, homogenized [OPG study]8.6918486
GSM549113patient 057, normal, homogenized [OPG study]8.5861285
GSM549132patient 031, cancer, homogenized [OPG study]8.3868584
GSM549137patient 038, cancer, homogenized [OPG study]8.7654887
GSM549142patient 047, cancer, homogenized [OPG study]7.727281
GSM549100patient 110, normal, homogenized [OPG study]8.3541485
GSM549107patient 135, normal, homogenized [OPG study]8.547785
GSM549115patient 068, normal, homogenized [OPG study]8.8023486
GSM549116patient 072, normal, homogenized [OPG study]8.4709184
GSM549120patient 078, normal, homogenized [OPG study]8.8879288
GSM549131patient 030, cancer, homogenized [OPG study]9.0364988
GSM549118patient 074, normal, homogenized [OPG study]8.2960983
GSM549129patient 027, cancer, homogenized [OPG study]8.3953185
GSM549123patient 088, normal, homogenized [OPG study]8.9657988
GSM549124patient 006, cancer, homogenized [OPG study]8.8806189
GSM549126patient 015, cancer, homogenized [OPG study]8.1891383
GSM549128patient 025, cancer, homogenized [OPG study]8.7570787
GSM549103patient 117, normal, homogenized [OPG study]8.1355784
GSM549117patient 073, normal, homogenized [OPG study]9.3479990
GSM549138patient 041, cancer, homogenized [OPG study]7.9259280
GSM549141patient 045, cancer, homogenized [OPG study]9.2494690
GSM549130patient 028, cancer, homogenized [OPG study]8.4639986
GSM549101patient 111, normal, homogenized [OPG study]8.4832286
GSM549105patient 128, normal, homogenized [OPG study]8.2872584
GSM549106patient 134, normal, homogenized [OPG study]5.4941951
GSM549112patient 048, normal, homogenized [OPG study]8.7843187
GSM549125patient 011, cancer, homogenized [OPG study]8.6182487
GSM549127patient 024, cancer, homogenized [OPG study]8.2323283
GSM549135patient 035, cancer, homogenized [OPG study]8.6297185